INSM (INSM) Stock Price & Analysis
INSM (INSM) fell 0.31% to USD 126.29 as of September 8, 2026 at 05:01 UTC, according to Nexqual real-time market data.
INSM last closed at USD 126.29; the session ranged USD 125.62–128.24 on volume of 1,802,693 shares. Market capitalization is —, with a 52-week range of USD 90.39–212.75 (NMS). Source: Nexqual, September 8, 2026 at 05:01 UTC.
Key Statistics (as of September 8, 2026 at 05:01 UTC)
| Price | USD 126.29 |
|---|---|
| Change | ▼ 0.31% (down) |
| Previous Close | USD 126.29 |
| Open | USD 126.29 |
| Day Range | USD 125.62 – 128.24 |
| 52-Week Range | USD 90.39 – 212.75 |
| Volume | 1,802,693 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (INSM)
Nexqual's technical model rates INSM "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 05:01 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 57.69 (neutral) |
| vs SMA50 | Above (USD 115.69) |
| MACD | 2.58 (positive) |
From INSM's Latest SEC 10-K Filing (filed 2026-02-19)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CYTK | Cytokinetics, Incorporated | USD 72.72 | ▲ 1.1% |
| ALNY | Alnylam Pharmaceuticals, Inc. | USD 266.11 | ▼ 0.48% |
| RARE | Ultragenyx Pharmaceutical Inc. | USD 15.3 | ▼ 42.33% |
| NTRA | Natera, Inc. | USD 328.18 | ▲ 0.93% |
| PTCT | PTC Therapeutics, Inc. | USD 69.3 | ▼ 3.47% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:01 UTC. This page is informational and not investment advice.